Certara and Merck announced an expansion of their clinical technology collaboration, which began on July 8, 2025.
1 report, 0 independent
Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Certara and Merck announced an expansion of their clinical technology collaboration, which began on July 8, 2025.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.Also in this story
- AstraZeneca's drug was tested in collaboration with Pfizer's drug.
- Pfizer acquired Biohaven Pharmaceuticals, Seagen, and Arena Pharmaceuticals in transactions dating back to 2022.
The entities involved
-
Certara (United States)
company in St Louis, United States
Nothing else this week.
-
Merck
public company in Indonesia
Coverage
Newest first; wire copies grouped- Unknown outlet